Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
(2019) 176:144760 e14
Managing CKD involves addressing inflammation, fibrosis, and oxidative stress, and targeting the pathways that alleviate the disease can lead to more effective treatments and better outcomes for CKD patients
The most common cause of anemia is a lack of iron, which your body needs to make hemoglobin
It is rare in plant-based products, so people with a vegan diet can often suffer from vitamin B12 deficiency and related symptoms
California research peptide catalog Premium research peptides
